Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05064306
Title 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

nephroblastoma

rhabdoid cancer

Ewing sarcoma

medulloblastoma

central nervous system primitive neuroectodermal neoplasm

embryonal cancer

retinoblastoma

pineoblastoma

neuroblastoma

hepatoblastoma

rhabdomyosarcoma

Therapies

Omburtamab I-131

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.